BIOVERATIV INC. Gross Profit
BIOVERATIV INC. reported Gross Profit of $258.40 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2018-02-14
- BIOVERATIV INC. gross profit for the quarter ending 2017-12-31 was $258.40M, a 43.16% increase year-over-year.
- BIOVERATIV INC. gross profit for the quarter ending 2017-09-30 was $226.10M, a 43.37% increase year-over-year.
- BIOVERATIV INC. gross profit for the quarter ending 2017-06-30 was $208.60M, a 37.15% increase year-over-year.
- BIOVERATIV INC. gross profit for the quarter ending 2017-03-31 was $195.80M, a 22.99% increase year-over-year.
- BIOVERATIV INC. gross profit for fiscal 2017 was $888.90M, a 36.86% increase from fiscal 2016.
- BIOVERATIV INC. gross profit for fiscal 2016 was $649.50M.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2017-12-31 | $258.40M 10-K · filed 2018-02-14 | $484.50M derived: sum of 2 quarters · filed 2018-02-14 | $693.10M derived: sum of 3 quarters · filed 2018-02-14 | $888.90M 10-K · filed 2018-02-14 |
| 2017-09-30 | $226.10M 10-K · filed 2018-02-14 | $434.70M derived: sum of 2 quarters · filed 2018-02-14 | $630.50M derived: sum of 3 quarters · filed 2018-02-14 | $811.00M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $208.60M 10-K · filed 2018-02-14 | $404.40M derived: sum of 2 quarters · filed 2018-02-14 | $584.90M derived: sum of 3 quarters · filed 2018-02-14 | $742.60M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $195.80M 10-K · filed 2018-02-14 | $376.30M derived: sum of 2 quarters · filed 2018-02-14 | $534.00M derived: sum of 3 quarters · filed 2018-02-14 | $686.10M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $180.50M 10-K · filed 2018-02-14 | $338.20M derived: sum of 2 quarters · filed 2018-02-14 | $490.30M derived: sum of 3 quarters · filed 2018-02-14 | $649.50M 10-K · filed 2018-02-14 |
| 2016-09-30 | $157.70M 10-K · filed 2018-02-14 | $309.80M derived: sum of 2 quarters · filed 2018-02-14 | $469.00M derived: sum of 3 quarters · filed 2018-02-14 | |
| 2016-06-30 | $152.10M 10-K · filed 2018-02-14 | $311.30M derived: sum of 2 quarters · filed 2018-02-14 | ||
| 2016-03-31 | $159.20M 10-K · filed 2018-02-14 |